1160 Cape Aire Lane
About iGenomXFounded in 2012, iGenomX initially sought to provide clinical sequencing for recessive genetic disorders. However, available commercial technology failed to produce a comprehensive test, missing nearly 30% of known causal mutations. Compelled to develop a technology that combines the best attributes of PCR, Microarray, Sanger Sequencing and Next Generation Sequencing, iGenomX soon began work on a low-cost sample preparation technology capable of detecting all genetic variation. Invented in the laboratory of Dr. Daniel Salomon at the Scripps Research Institute (La Jolla, CA) and licensed exclusively to iGenomX, this technology has become the core of all iGenomX NGS applications. In 2014, iGenomX began operations in Southern California to further develop the technology and Intellectual Property.
Founder and CEO: Keith Brown
CSO: Daniel Salomon
8 articles with iGenomX
Twist Bioscience Corporation today announced the acquisition of iGenomX , a company offering multiplex library preparation tools for next-generation sequencing (NGS) workflows.
Reproductive Genetics To Enable Higher Success Rates And Prevent Transmission Of Genetic Disorders: iGenomX
iGenomX Becomes The First Private Genetic Laboratory In Middle East To Be Accredited By College of American Pathologists